Loading company…
Yongin-based company, founded in 2021, developing lipid nanoparticle carriers that improve delivery of RNA and DNA gene-based medicines.
Based in Yongin, South Korea, and founded in 2021, MediciBIO Co., Ltd. develops lipid nanoparticle drug delivery technologies for gene-based medicines. Its proprietary lipid carriers aim to improve delivery of RNA and DNA therapies, vaccines and treatments for genetic diseases while reducing immune reactions and side effects.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in